| Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers? G Marisi, A Cucchetti, P Ulivi, M Canale, G Cabibbo, L Solaini, FG Foschi, ... World journal of gastroenterology 24 (36), 4152, 2018 | 172 | 2018 |
| Aberrant metabolism in hepatocellular carcinoma provides diagnostic and therapeutic opportunities S De Matteis, A Ragusa, G Marisi, S De Domenico, A Casadei Gardini, ... Oxidative medicine and cellular longevity 2018 (1), 7512159, 2018 | 139 | 2018 |
| Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale AC Gardini, L Faloppi, S De Matteis, FG Foschi, N Silvestris, F Tovoli, ... European Journal of Cancer 86, 106-114, 2017 | 96 | 2017 |
| NMR-based metabolomic approach tracks potential serum biomarkers of disease progression in patients with type 2 diabetes mellitus L Del Coco, D Vergara, S De Matteis, E Mensà, J Sabbatinelli, ... Journal of clinical medicine 8 (5), 720, 2019 | 68 | 2019 |
| Targeting of GSK3β promotes imatinib-mediated apoptosis in quiescent CD34+ chronic myeloid leukemia progenitors, preserving normal stem cells G Reddiconto, C Toto, I Palamà, S De Leo, E de Luca, S De Matteis, ... Blood, The Journal of the American Society of Hematology 119 (10), 2335-2345, 2012 | 66 | 2012 |
| Age-related M1/M2 phenotype changes in circulating monocytes from healthy/unhealthy individuals A Costantini, N Viola, A Berretta, R Galeazzi, G Matacchione, ... Aging (Albany NY) 10 (6), 1268, 2018 | 63 | 2018 |
| Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia A Ghelli Luserna Di Rorà, N Beeharry, E Imbrogno, A Ferrari, V Robustelli, ... Journal of hematology & oncology 11, 1-18, 2018 | 41 | 2018 |
| IL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia G Musuraca, S De Matteis, R Napolitano, C Papayannidis, ... Journal of translational medicine 13, 1-10, 2015 | 34 | 2015 |
| Immunosuppressive Treg cells acquire the phenotype of effector-T cells in chronic lymphocytic leukemia patients S De Matteis, C Molinari, G Abbati, T Rossi, R Napolitano, M Ghetti, ... Journal of translational medicine 16, 1-9, 2018 | 33 | 2018 |
| Role of SIRT-3, p-mTOR and HIF-1α in hepatocellular carcinoma patients affected by metabolic dysfunctions and in chronic treatment with metformin S De Matteis, E Scarpi, AM Granato, U Vespasiani-Gentilucci, G La Barba, ... International Journal of Molecular Sciences 20 (6), 1503, 2019 | 30 | 2019 |
| Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinoma M Canale, P Ulivi, FG Foschi, E Scarpi, S De Matteis, G Donati, G Ercolani, ... Critical Reviews in Oncology/Hematology 129, 44-53, 2018 | 30 | 2018 |
| High levels of circulating monocytic myeloid-derived suppressive-like cells are associated with the primary resistance to immune checkpoint inhibitors in advanced non-small … G Bronte, E Petracci, S De Matteis, M Canale, I Zampiva, I Priano, ... Frontiers in immunology 13, 866561, 2022 | 24 | 2022 |
| The multifaceted role of TGF-β in gastrointestinal tumors F Sabbadini, M Bertolini, S De Matteis, D Mangiameli, S Contarelli, ... Cancers 13 (16), 3960, 2021 | 23 | 2021 |
| Advances in Molecular Mechanisms and Immunotherapy Involving the Immune Cell-Promoted Epithelial-to-Mesenchymal Transition in Lung Cancer S De Matteis, M Canale, A Verlicchi, G Bronte, A Delmonte, L Crinò, ... Journal of Oncology, 2019 | 21 | 2019 |
| Interplay between SIRT-3, metabolism and its tumor suppressor role in hepatocellular carcinoma S De Matteis, AM Granato, R Napolitano, C Molinari, M Valgiusti, ... Digestive diseases and sciences 62, 1872-1880, 2017 | 15 | 2017 |
| Kevetrin induces apoptosis in TP53 wild-type and mutant acute myeloid leukemia cells R Napolitano, S De Matteis, S Carloni, S Bruno, G Abbati, L Capelli, ... Oncology reports 44 (4), 1561-1573, 2020 | 14 | 2020 |
| Comparative proteomic profiling of Hodgkin lymphoma cell lines D Vergara, P Simeone, S De Matteis, S Carloni, P Lanuti, M Marchisio, ... Molecular BioSystems 12 (1), 219-232, 2016 | 12 | 2016 |
| Fulminant cerebral edema following CAR T-cell therapy: case report and pathophysiological insights from literature review U Pensato, L Muccioli, P Zinzani, R D’Angelo, E Pierucci, B Casadei, ... Journal of Neurology 269 (8), 4560-4563, 2022 | 10 | 2022 |
| The emerging role of GSK‐3β in the pathobiology of classical Hodgkin lymphoma C Agostinelli, S Carloni, F Limarzi, S Righi, MA Laginestra, G Musuraca, ... Histopathology 71 (1), 72-80, 2017 | 10 | 2017 |
| Pentoxifylline-induced apoptosis in chronic lymphocytic leukemia: new insights into molecular mechanism R Napolitano, S De Matteis, A Lucchesi, S Carloni, D Cangini, ... Mini reviews in medicinal chemistry 18 (3), 287-294, 2018 | 8 | 2018 |
